Cision Press Releases

BioStock: Robust data drives Alligator Bioscience forward




Alligator Bioscience has certainly had a successful 2024 according to its Q3 report. With promising phase II results from its leading drug candidate mitazalimab, strong partnerships, and a clear strategy for the future, the company is poised to make significant strides in cancer treatment. Alligator is continuing to invest in preparing mitazalimab for phase III, to be able to initiate a trial in H1 2025, while maturing its ongoing dialogue with global pharma companies regarding a potential partnership.

Read the article about Alligator Bioscience at biostock.se:

https://www.biostock.se/en/2024/10/robust-data-drives-alligator-bioscience-forward/

This is a press release from BioStock – Connecting Innovation & Capitalhttps://www.biostock.se/en/




Source link

creativebharatgroup@gmail.com

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Cision Press Releases

Clocks Going Back: 5 Quick DIY Jobs You Can Do With The Extra Hour

  Each year, the clocks go back at 2 am on the last Sunday of